aTyr Pharma, Inc.
ATYR
$4.07
$0.0751.88%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -63.82M | -57.90M | -53.93M | -50.39M | -43.15M |
| Total Depreciation and Amortization | 1.95M | 2.55M | 2.76M | 2.74M | 3.03M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -162.00K | -618.00K | -851.00K | -585.00K | 217.00K |
| Change in Net Operating Assets | -5.02M | -7.49M | -2.99M | 15.01M | 7.37M |
| Cash from Operations | -67.05M | -63.45M | -55.01M | -33.22M | -32.53M |
| Capital Expenditure | -57.00K | -599.00K | -2.99M | -4.22M | -5.32M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 15.00K | 15.00K | 15.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.19M | 28.17M | 19.66M | -15.93M | -30.64M |
| Cash from Investing | 41.14M | 27.57M | 16.69M | -20.13M | -35.95M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -484.00K | -467.00K | -449.00K | -394.00K | -345.00K |
| Issuance of Common Stock | 27.54M | 30.31M | 24.91M | 66.62M | 61.44M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 24.00K |
| Cash from Financing | 27.06M | 29.85M | 24.46M | 66.23M | 61.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.15M | -6.03M | -13.86M | 12.88M | -7.36M |
